SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950170-23-059485
Filing Date
2023-11-06
Accepted
2023-11-06 16:48:50
Documents
72
Period of Report
2023-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q dawn-20230930.htm   iXBRL 10-Q 3147451
2 EX-31.1 dawn-ex31_1.htm EX-31.1 14664
3 EX-31.2 dawn-ex31_2.htm EX-31.2 14472
4 EX-32.1 dawn-ex32_1.htm EX-32.1 8551
5 EX-32.2 dawn-ex32_2.htm EX-32.2 9576
6 GRAPHIC img12645694_0.jpg GRAPHIC 230693
  Complete submission text file 0000950170-23-059485.txt   11636612

Data Files

Seq Description Document Type Size
7 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT dawn-20230930.xsd EX-101.SCH 66856
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT dawn-20230930_lab.xml EX-101.LAB 489877
9 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT dawn-20230930_cal.xml EX-101.CAL 39929
10 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT dawn-20230930_def.xml EX-101.DEF 329545
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT dawn-20230930_pre.xml EX-101.PRE 442205
66 EXTRACTED XBRL INSTANCE DOCUMENT dawn-20230930_htm.xml XML 2225936
Mailing Address 2000 SIERRA POINT PARKWAY, SUITE 501 BRISBANE CA 94005
Business Address 2000 SIERRA POINT PARKWAY, SUITE 501 BRISBANE CA 94005 650 484-0899
Day One Biopharmaceuticals, Inc. (Filer) CIK: 0001845337 (see all company filings)

IRS No.: 832415215 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-40431 | Film No.: 231380535
SIC: 2834 Pharmaceutical Preparations